Clin2
NCT06382389Possibly a fitNot yet recruiting

Gas treatment added to antidepressants for depression in dementia

DepressionNeurocognitive Disorders

Part of Mental health clinical trials.

This trial tests whether adding a special gas called EMONO (a mix of oxygen and nitrous oxide) to your regular antidepressant can improve depression symptoms in people with dementia living in nursing homes. You would receive the gas for a short time during the study.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
96 people
Ages
60 years and older
Study type
Interventional

Who can take part

  • You are 60 or older and live in a nursing home.
  • You have a major memory or thinking disorder (like dementia) diagnosed by a doctor for at least 6 months.
  • You have symptoms of depression, as shown by a score of 4 or more on a standard depression scale.
  • You are already taking antidepressant medication.
  • You do not have severe agitation or behaviors that are very hard to manage.
  • You have not used a gas mixture called MEOPA (a mix of oxygen and nitrous oxide) in the past 6 months.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06557642Recruiting
Laughing Gas and Emotional Thinking Study

This study tests how nitrous oxide (laughing gas) affects your emotions and thinking. It's looking for healthy volunteers ages 18 to 40 to see how the gas might change emotional processing.

Oxford
NCT03736538Enrolling by invitation· Phase 1
Nitrous oxide for suicidal thoughts in depression

This Phase 1 study tests whether breathing nitrous oxide can safely reduce suicidal thoughts in adults with major depression. It may help people whose depression is causing moderate to severe suicidal thinking, by studying a fast-acting treatment approach.

St Louis, Missouri
NCT06075771Recruiting· Phase 4
Testing a Parkinson's drug for depression-related loss of interest

This trial tests whether a medication used for Parkinson's disease (carbidopa-levodopa) can help people with major depression who have lost interest or pleasure in things. It is for adults who have not been helped enough by other treatments and have signs of inflammation.

Atlanta, Georgia
NCT02994433Recruiting· Phase 1
Testing nitrous oxide for depression brain circuit activity

This early study tests whether nitrous oxide, aimed at specific brain circuits, can change depression-related brain activity. It is mainly for adults with major depression or treatment-resistant depression, and includes brain imaging during the study.

St Louis, Missouri
NCT07262008Not yet recruiting· Phase 3
Laughing gas for mood improvement in depression

This study tests if laughing gas (nitrous oxide) can help improve mood in people with major depression. You will receive either laughing gas or a placebo, and your mood will be monitored over time.

Toronto, Ontario
NCT07139834Recruiting· Phase 1
Memory and mood study for depression

This study tests how a medication called memantine affects memory and mood in people with major depression who are not currently taking antidepressants. It involves MRI scans and may help find new ways to treat depression.

New York, New York

Hear when a new Depression trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.